{"id":266877,"date":"2022-04-28T08:43:31","date_gmt":"2022-04-28T13:43:31","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=266877"},"modified":"2022-04-29T00:54:22","modified_gmt":"2022-04-29T05:54:22","slug":"tech-companies-moving-take-fertility-diagnostic","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/","title":{"rendered":"Tech company interest in fertility industry will increase the disposal of ‘unfit’ children"},"content":{"rendered":"
<\/div>
\n

At its core, in vitro fertilization (IVF) appears to be pro-life. Yet, the process includes the weeding out of human embryos \u2014 human beings \u2014 who have been deemed “unfit” by fertility industry standards. As a takeover battle ensues\u00a0over Australian IVF business Virtus Health, the fact that the fertility industry is focused on “quality control” and financial profit can no longer be ignored.<\/p>\n

According to a report by The Sydney Morning Herald<\/a>, the fertility industry faced setbacks following the elective surgery lockdowns in the early days of the COVID-19 pandemic. But since then, there has been a significant uptick in patients seeking fertility treatments. In 2021, Virtus saw a 26% increase in new patients. Monash IVF, which boasts “robust quality assurance processes” saw a 40% jump. In the U.S., Carolina Conceptions has seen a 30% increase in patients over the last two years.<\/p>\n

Discarding poor “quality” humans<\/strong><\/p>\n

UK-based CapVest Partners and BGH Capital are in a buyout war over Virtus Health, and at the center of the discussion is how far technology will take the fertility industry, including Virtus, in terms of live-birth success, the weeding out of children with health conditions, and financial profit<\/a>.<\/p>\n

\u201cI think that the innovation that is likely to occur in IVF and assisted reproductive services is going to accelerate. Private funding does lend itself to investing in organisations like ours and accelerating that potential,\u201d said<\/a> Kate Munnings, chief executive officer and managing director of Virtus Health.<\/p>\n

Currently, the IVF process often involves screening embryos through pre-implantation genetic testing (PGT) also known as pre-implantation genetic diagnosis (PGD). This allows fertility specialists to target children with genetic conditions such as Down syndrome and cystic fibrosis by testing the embryos for these health conditions before attempting to implant them. The embryos that receive a diagnosis face destruction or are sentenced to the lab for research and then destruction.<\/p>\n

Embryos are also graded on their “quality,” which is incredibly dehumanizing. Those who don’t make the cut are discarded and many couples must agree to this ahead of time. Embryos labeled “aneuploid,” meaning he or she has an abnormal number of chromosomes, are often automatically thrown out because they are believed to have little to no chance of developing properly. However, new evidence<\/a> is showing that these embryos can actually self-correct.<\/p>\n<\/div>\n

This discrimination is just the beginning. Virtus is now working with an intelligence tool called IVY Artificial Intelligence<\/a>, which works using artificial intelligence (AI) to select embryos that the computer believes have the best chance of surviving long enough that the heart develops \u2014 usually about 21 days after fertilization. As explained by IVF.com.au<\/a>:<\/p>\n

Artificial intelligence performs a comprehensive assessment of the growth of the embryos over all five days and then relates this data to whether a fetal heart has developed or not. By completely objective analysis of the images, the artificial intelligence system\u00a0has taught itself to identify the embryo with the greatest likelihood of developing as far as a fetal heart. The embryo with the highest score, and therefore the highest potential for leading to a viable fetus, can then be selected for transfer.<\/em><\/p>\n

Virtus used IVY to review data obtained from 10,638 embryos using time-lapse videos from eight different Virtus Health IVF clinics in four different countries. Out of those 10,638 embryos, only 694 have been confirmed in positive pregnancies. More than 7,000 were discarded, and more than 1600 were still frozen at the time the study was published. Using AI, human embryos that may have been transferred in the past may be discarded because the computer determined them to be inadequate.<\/p>\n

\"\"<\/a>

https:\/\/academic.oup.com\/humrep\/article\/34\/6\/1011\/5491340<\/p><\/div>\n

The company is also working to launch Precision Fertility<\/a>, which will merge patient information with artificial intelligence tools in order to create better outcomes in IVF. This includes innovations in the use of egg and sperm donations to create the desired child. These practices have long be plagued by discriminatory practices.<\/p>\n

The\u00a0Repository for Germinal Choice<\/a>\u00a0existed to create \u201csuper-kids\u201d using the sperm of high-achieving men. It was nicknamed the \u201cNobel Prize sperm bank” as the man behind the repository, Robert Klark Graham, took home the Ig Nobel in 1991 for the repository. The men who “donated” were all white and were required to be married heterosexuals along with other criteria. Women were only allowed to receive the sperm if they fit the same conditions. This would create what were expected to be white, highly intelligent babies. The bank ultimately failed, but its unethical practices still echo through the industry.<\/p>\n

In 2015, the London Sperm Bank was under investigation<\/a> for eugenic practices because it banned men with certain common conditions such as dyslexia and ADHD from selling their sperm. Egg donation advertisements paint a similar picture that these companies only want people of a certain race and appearance to contribute their eggs. Some companies have said they will only take women 5’9″ or taller, with an SAT score of 1500 or higher, and with athletic abilities. With the advancement of technology, these expectations will not disappear \u2014 they will only expand.<\/p>\n

\u201c[Technology] is going to be a game-changer for our sector \u2014 I think in five years, it\u2019s going to be really transformational,” said Munnings.<\/p>\n

According to a Harvard University\u00a0study<\/a>, 62% of children conceived through donor technologies, including surrogacy, believe it to be\u00a0unethical<\/a>. One woman\u00a0told<\/a>\u00a0the pro-children\u2019s rights organization Them Before Us, \u201cSomehow, somewhere, my parents developed the idea that they deserved to have a baby, and it didn\u2019t matter how much it cost, how many times it took, or how many died in the process. They deserved a child. And with an attitude like that, by the time I was born they thought they deserved to have the perfect child\u2026 as Dad defined a perfect child. And since they deserved a child, I was their property to be controlled, not a person or a gift to be treasured.\u201d<\/p>\n

Funding the future of IVF<\/strong><\/p>\n

Writing for Forbes<\/a> in 2020, Claire Tomkins, Founder and CEO of Future Family made five fertility industry predictions. The first was: “Investor funding in the space will surge.”<\/p>\n

She continued, “It’s becoming clear to investors that there’s a huge market for fertility services, especially as more women are having kids in their 30s and need to turn to alternative methods to conceive. [In 2019], venture capitalists and private equity firms poured over $624 million … into the fertility space, up from $200 million in 2009.”<\/p>\n

All of that money works to “innovate” the IVF system. That is Tomkins’ second prediction. “As more money flows into the industry, we can expect to see a rise in entrepreneurs entering the space, fueling innovation at an increased pace,” she explained. “Not only will these new companies make existing fertility solutions available to people who previously didn’t have access to them, but they’ll also undoubtedly bring with them new solutions, such as software, diagnostic tools, products and services.”<\/p>\n

There can be no mistake that innovations in “diagnostic tools” will be used to target even more children with disabilities or health conditions for destruction during the IVF process. But as recent reports<\/a> on the accuracy of prenatal testing have shown, there is a lot of room for error. Regardless of whether or not the “diagnostic tools” are accurate, no child \u2014 even in the embryonic stage \u2014 should be discarded due to a diagnosis. Further innovation in the fertility industry diagnostic tools will inevitably lead to more destruction.<\/p>\n

It isn’t just investors who will help fuel the destruction of human life at the embryonic stage.\u00a0In Australia, Health Minister Greg Hunt announced Medicare will now offer rebates for five types of PGT \u2014 likely so that certain babies with certain medical conditions will not be born and therefore not cost the government money through the nation’s government-funded health care. Australia already has a history of trying to force immigrants<\/a> with disabilities<\/a> out of the country. And now the nation appears to be positioning itself to ensure citizens with certain health conditions are never born.<\/p>\n

Fertility companies expect to see a large post-pandemic IVF baby boom in an industry that was already<\/em> expected<\/a> to reach $41.4 billion by 2026.\u00a0Virtus stock has surged since the bidding war began. No matter which company wins out in the end, ultimately it is the children that lose out: the one million children left frozen indefinitely, the countless children discriminated against and destroyed, the children facing an identity crisis due to the circumstances of their conception, and the children born under the expectation of perfection.<\/p>\n

\u201cLike\u201d Live Action News on Facebook<\/a>\u00a0for more pro-life news and commentary!<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

At its core, in vitro fertilization (IVF) appears to be pro-life. Yet, the process includes the weeding out of human embryos \u2014 human beings \u2014 who have been deemed “unfit” by fertility industry standards. As a takeover battle ensues\u00a0over Australian IVF business Virtus Health, the fact that the fertility industry is focused on “quality control” […]<\/p>\n","protected":false},"author":62,"featured_media":216830,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false},"categories":[15,3],"tags":[964,17071,17070,17066,4879,17067,756,17068,1189,17069],"yoast_head":"\nTech company interest in fertility industry will increase the disposal of 'unfit' children<\/title>\n<meta name=\"description\" content=\"As a takeover battle ensues\u00a0over an Australian IVF business, the fertility industry's focus on "quality control" and profit can no longer be ignored.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tech company interest in fertility industry will increase the disposal of 'unfit' children\" \/>\n<meta property=\"og:description\" content=\"As a takeover battle ensues\u00a0over an Australian IVF business, the fertility industry's focus on "quality control" and profit can no longer be ignored.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Action News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/liveaction\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-28T13:43:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-29T05:54:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2020\/01\/GettyImages-488635667-IVF.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1191\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nancy Flanders\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@liveaction\" \/>\n<meta name=\"twitter:site\" content=\"@liveaction\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nancy Flanders\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\"},\"author\":{\"name\":\"Nancy Flanders\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/d61ca3dd1aacf12635bdf71d75c328ef\"},\"headline\":\"Tech company interest in fertility industry will increase the disposal of ‘unfit’ children\",\"datePublished\":\"2022-04-28T13:43:31+00:00\",\"dateModified\":\"2022-04-29T05:54:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\"},\"wordCount\":1435,\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"keywords\":[\"australia\",\"BGH Capital\",\"CapVest Partners\",\"diagnostic\",\"fertility\",\"Future Family\",\"IVF\",\"Precision Fertility\",\"tech\",\"Virtue Health\"],\"articleSection\":[\"Analysis\",\"Opinion\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\",\"name\":\"Tech company interest in fertility industry will increase the disposal of 'unfit' children\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\"},\"datePublished\":\"2022-04-28T13:43:31+00:00\",\"dateModified\":\"2022-04-29T05:54:22+00:00\",\"description\":\"As a takeover battle ensues\u00a0over an Australian IVF business, the fertility industry's focus on \\\"quality control\\\" and profit can no longer be ignored.\",\"breadcrumb\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/archive.liveaction.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tech company interest in fertility industry will increase the disposal of ‘unfit’ children\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"name\":\"Live Action News\",\"description\":\"Covering Human Rights, Abortion, & Pro-Life Issues\",\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\",\"name\":\"Live Action\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"contentUrl\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"width\":701,\"height\":710,\"caption\":\"Live Action\"},\"image\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/liveaction\",\"https:\/\/twitter.com\/liveaction\",\"https:\/\/www.instagram.com\/liveactionorg\/\",\"https:\/\/www.pinterest.com\/LiveActionFilms\/\",\"https:\/\/www.youtube.com\/user\/LiveActionFilms\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/d61ca3dd1aacf12635bdf71d75c328ef\",\"name\":\"Nancy Flanders\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/dee54060bdc22fdfbf36d946b3026cca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/dee54060bdc22fdfbf36d946b3026cca?s=96&d=mm&r=g\",\"caption\":\"Nancy Flanders\"},\"description\":\"Nancy Flanders is Associate Editor for Live Action News. She has 25 years of experience writing and editing. For more than a decade, she has focused her work on pro-life issues through human interest stories and political issues regarding abortion and physician-assisted death as well as research articles and op-eds dismantling the lies of the pro-abortion, pro-death agenda. Her work has appeared in Catholic Digest, Pregnancy Help News, and a variety of other publications.\",\"url\":\"https:\/\/archive.liveaction.org\/news\/author\/nancy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tech company interest in fertility industry will increase the disposal of 'unfit' children","description":"As a takeover battle ensues\u00a0over an Australian IVF business, the fertility industry's focus on \"quality control\" and profit can no longer be ignored.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/","og_locale":"en_US","og_type":"article","og_title":"Tech company interest in fertility industry will increase the disposal of 'unfit' children","og_description":"As a takeover battle ensues\u00a0over an Australian IVF business, the fertility industry's focus on \"quality control\" and profit can no longer be ignored.","og_url":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/","og_site_name":"Live Action News","article_publisher":"https:\/\/www.facebook.com\/liveaction","article_published_time":"2022-04-28T13:43:31+00:00","article_modified_time":"2022-04-29T05:54:22+00:00","og_image":[{"width":1191,"height":650,"url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2020\/01\/GettyImages-488635667-IVF.jpg","type":"image\/jpeg"}],"author":"Nancy Flanders","twitter_card":"summary_large_image","twitter_creator":"@liveaction","twitter_site":"@liveaction","twitter_misc":{"Written by":"Nancy Flanders","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/#article","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/"},"author":{"name":"Nancy Flanders","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/d61ca3dd1aacf12635bdf71d75c328ef"},"headline":"Tech company interest in fertility industry will increase the disposal of ‘unfit’ children","datePublished":"2022-04-28T13:43:31+00:00","dateModified":"2022-04-29T05:54:22+00:00","mainEntityOfPage":{"@id":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/"},"wordCount":1435,"publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"keywords":["australia","BGH Capital","CapVest Partners","diagnostic","fertility","Future Family","IVF","Precision Fertility","tech","Virtue Health"],"articleSection":["Analysis","Opinion"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/","url":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/","name":"Tech company interest in fertility industry will increase the disposal of 'unfit' children","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/#website"},"datePublished":"2022-04-28T13:43:31+00:00","dateModified":"2022-04-29T05:54:22+00:00","description":"As a takeover battle ensues\u00a0over an Australian IVF business, the fertility industry's focus on \"quality control\" and profit can no longer be ignored.","breadcrumb":{"@id":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/archive.liveaction.org\/news\/tech-companies-moving-take-fertility-diagnostic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/archive.liveaction.org\/news\/"},{"@type":"ListItem","position":2,"name":"Tech company interest in fertility industry will increase the disposal of ‘unfit’ children"}]},{"@type":"WebSite","@id":"https:\/\/archive.liveaction.org\/news\/#website","url":"https:\/\/archive.liveaction.org\/news\/","name":"Live Action News","description":"Covering Human Rights, Abortion, & Pro-Life Issues","publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/archive.liveaction.org\/news\/#organization","name":"Live Action","url":"https:\/\/archive.liveaction.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","contentUrl":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","width":701,"height":710,"caption":"Live Action"},"image":{"@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/liveaction","https:\/\/twitter.com\/liveaction","https:\/\/www.instagram.com\/liveactionorg\/","https:\/\/www.pinterest.com\/LiveActionFilms\/","https:\/\/www.youtube.com\/user\/LiveActionFilms"]},{"@type":"Person","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/d61ca3dd1aacf12635bdf71d75c328ef","name":"Nancy Flanders","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/dee54060bdc22fdfbf36d946b3026cca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dee54060bdc22fdfbf36d946b3026cca?s=96&d=mm&r=g","caption":"Nancy Flanders"},"description":"Nancy Flanders is Associate Editor for Live Action News. She has 25 years of experience writing and editing. For more than a decade, she has focused her work on pro-life issues through human interest stories and political issues regarding abortion and physician-assisted death as well as research articles and op-eds dismantling the lies of the pro-abortion, pro-death agenda. Her work has appeared in Catholic Digest, Pregnancy Help News, and a variety of other publications.","url":"https:\/\/archive.liveaction.org\/news\/author\/nancy\/"}]}},"_links":{"self":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/266877"}],"collection":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/users\/62"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/comments?post=266877"}],"version-history":[{"count":8,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/266877\/revisions"}],"predecessor-version":[{"id":267157,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/266877\/revisions\/267157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media\/216830"}],"wp:attachment":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media?parent=266877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/categories?post=266877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/tags?post=266877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}